Minerva Neurosciences
Minerva Neurosciences, Inc.(NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on the development of a portfolio of product candidates to treat central nervous system (CNS) diseases. Our goal is to transform the lives of patients with improved therapeutic options. Leveraging extensive domain expertise, we have identified and acquired or in-licensed a portfolio of development-stage proprietary compounds with what we believe are innovative mechanisms of action. Our executive management team includes globally recognized specialists in central nervous system diseases addressing significant unmet medical needs.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
8
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
1
tools in use
Monthly traffic
876
organic / mo
Sign up free to see all 5 verified contacts at Minerva Neurosciences
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- AA
Anthony Aliquo
Vice President, Controller · Finance & Accounting
EmailPhone - AR
Andre Richer
VP Program Management · Other
EmailPhone - MD
Michael Davidson
Chief Medical Officer · Healthcare & Human Services
EmailPhone
Showing 3 of 5 verified contacts
Top roles at Minerva Neurosciences
4 distinct titles indexed · top 4 shown.
- 1chief medical officer
- 1senior vice president and head of r & d
- 1vice president, controller
- 1vp program management
Sign up to unlock all 5 contacts at Minerva Neurosciences
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Minerva Neurosciences
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.